{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:46:20Z","timestamp":1760607980053},"reference-count":23,"publisher":"Japanese Circulation Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn Circ J"],"published-print":{"date-parts":[[2000]]},"DOI":"10.1253\/jcj.64.249","type":"journal-article","created":{"date-parts":[[2002,9,11]],"date-time":"2002-09-11T02:17:28Z","timestamp":1031710648000},"page":"249-253","source":"Crossref","is-referenced-by-count":2,"title":["Hemodynamic Effects of Phosphodiesterase III Inhibitor in Patients With a Large Ventricular Left-to-Right Shunt"],"prefix":"10.1253","volume":"64","author":[{"given":"Nobuo","family":"Momoi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University, Hikarigaoka, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University, Hikarigaoka, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University, Hikarigaoka, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University, Hikarigaoka, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University, Hikarigaoka, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University, Hikarigaoka, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University, Hikarigaoka, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jenkins IR, Dolman J, Connor JP, Ansley DM: Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: A prospective, randomized double-blind trial. Anaesth Intensive Care 1997; 25: 245-249","DOI":"10.1177\/0310057X9702500306"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gage J, Rutman H, Lucido D, LeJelntel TH: Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure. Circulation 1986; 74: 367-373","DOI":"10.1161\/01.CIR.74.2.367"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gilbert EM, Hershberger RE, Wiechmann BJ, Movsesian MA, Bristow MR: Pharmacologic and hemodynamic effects of combined &beta;-agonist stimulation and phosphodiesterase inhibition in the falling human heart. Chest 1995; 108: 1524-1532","DOI":"10.1378\/chest.108.6.1524"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Feneck RO, European Milrinone Multicentre Trial Group: Intravenous Milrinone following cardiac surgery. I. Effects of bolus infusion followed by variable dose maintenance infusion. J Cardiothorac Vasc Anesth 1992; 6: 554-562","DOI":"10.1016\/1053-0770(92)90097-Q"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bailey JM, Miller BE, Kanter KR, Tosone SR, Tam VKH: A comparison of the hemodynamic effects of Amrinone and sodium nitroprusside in infants after cardiac surgery. Anesth Analg 1997; 84: 294-298","DOI":"10.1213\/00000539-199702000-00010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS: Positive inotropic and vasodilator actions of Milrinone in patients with severe congestive heart failure. J Clin Invest 1985; 75: 643-649","DOI":"10.1172\/JCI111742"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90834-5"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(93)90174-8"},{"key":"9","unstructured":"9. Kikura M, Levy JH, Michelsen LG, Shanewise JS, Bailey JM, Sadel SM, et al: The effect of Milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass. Anesth Analg 1997; 85: 16-22"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1007\/s002469900047"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199706000-00009"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sundram P, Reddy HK, McElroy PA, Janicki JS, Weber KT: Myocardial energetics and efficiency in patients with idiopathic cardiomyopathy: Response to dobutamine and amrinone. Am Heart J 1990; 119: 891-898","DOI":"10.1016\/S0002-8703(05)80328-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takaoka H, Takeuchi M. Hata K, Hayashi Y, Mori M, Yamakawa H, et al: Beneficial effects of Ca<SUP>2+<\/SUP> sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: Comparison with dobutamine and phosphodiesterase inhibitor. Am Heart J 1997; 133: 283-289","DOI":"10.1016\/S0002-8703(97)70221-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Takaoka H, Odake M, Hayashi Y, Mori M, Hata K, Yokoyama M: Comparison of the effects on arterial-ventricular coupling between phosphodiesterase inhibitor and dobutamine in the diseased human heart. J Am Coll Cardiol 1993; 22: 598-606","DOI":"10.1016\/0735-1097(93)90071-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL: Milrinone: systemic and pulmonary hemodynamic effects in neonate after cardiac surgery. Crit Care Med 1995; 23: 1907-1914","DOI":"10.1097\/00003246-199511000-00018"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90336-6"},{"key":"17","unstructured":"17. Colucci WS, Leatherman GF, Ludmer PL, Gauthier DF: &beta;-adrenergic inotropic responsiveness of patients with heart failure: Studies with intracoronary dobutamine infusion. Circ Res 1987; 61 (Suppl 1): 82-86"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(95)02397-F"},{"issue":"1","key":"19","first-page":"33","volume":"39","year":"1989","ISSN":"http:\/\/id.crossref.org\/issn\/0004-4172","issn-type":"print"},{"issue":"1","key":"20","first-page":"38","volume":"39","year":"1989","ISSN":"http:\/\/id.crossref.org\/issn\/0004-4172","issn-type":"print"},{"key":"21","unstructured":"21. Murakami R, Morioka S, Moriyama K, Ishibashi Y: Differential hemodynamic effects of new cardiotonic agent E-1020 and dobutamine on acute heart failure. Jpn J Clin Exp Med 1992; 70: 1265-1272"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1006\/pulp.1994.1009"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199801000-00012"}],"container-title":["Japanese Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jcj\/64\/4\/64_4_249\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T02:26:26Z","timestamp":1616725586000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jcj\/64\/4\/64_4_249\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000]]}},"URL":"https:\/\/doi.org\/10.1253\/jcj.64.249","relation":{},"ISSN":["0047-1828","1347-4839"],"issn-type":[{"value":"0047-1828","type":"print"},{"value":"1347-4839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000]]}}}